These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 17329287)
21. The Purdue Pharma Opioid Settlement - Accountability, or Just the Cost of Doing Business? Davis CS N Engl J Med; 2021 Jan; 384(2):97-99. PubMed ID: 33502834 [No Abstract] [Full Text] [Related]
22. Objects closer than they appear: regulating health-based advertising of food. Marks JH Am J Bioeth; 2013; 13(5):23-5. PubMed ID: 23557041 [No Abstract] [Full Text] [Related]
23. Disease-branding and drug-mongering: could pharmaceutical industry promotional practices result in tort liability? Cetel JS Seton Hall Law Rev; 2012; 42(2):643-702. PubMed ID: 22708139 [No Abstract] [Full Text] [Related]
24. Augmenting the argument against indirect medical advertising. Trafimow D Am J Bioeth; 2013; 13(5):21-3. PubMed ID: 23557040 [No Abstract] [Full Text] [Related]
25. The dilemma in regulating drug advertising: propositional versus nonpropositional content. Krimsky S Am J Bioeth; 2013; 13(5):16-7. PubMed ID: 23557037 [No Abstract] [Full Text] [Related]
26. Proposed guidelines for housestaff interaction with pharmaceutical companies. Forrest DM; Ruedy J Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243 [TBL] [Abstract][Full Text] [Related]
27. As doctor writes prescription, drug company writes a check. Harris G N Y Times Web; 2004 Jun; ():A1, A19. PubMed ID: 15290802 [No Abstract] [Full Text] [Related]
28. Inching toward health decision exceptionalism. Stark M; Fins JJ Am J Bioeth; 2013; 13(5):18-9. PubMed ID: 23557038 [No Abstract] [Full Text] [Related]
29. Wyeth found guilty of paying to boost use of a specific medicine. Kmietowicz Z BMJ; 2004 Jun; 328(7455):1515. PubMed ID: 15217852 [No Abstract] [Full Text] [Related]
30. Curbing the influence of the drug industry: a British view. Smith R PLoS Med; 2005 Sep; 2(9):e241. PubMed ID: 16076242 [TBL] [Abstract][Full Text] [Related]
31. US judge fines Johnson & Johnson $1.1bn for misleading marketing of risperidone. Tanne JH BMJ; 2012 Apr; 344():e2772. PubMed ID: 22508952 [No Abstract] [Full Text] [Related]
32. Can advocates keep congress focused on HIV? AIDS Alert; 2001 Dec; 16(12):157-8. PubMed ID: 11768874 [No Abstract] [Full Text] [Related]
33. Gaviscon maker is accused of rigging the market. Kmietowicz Z BMJ; 2010 Feb; 340():c1121. PubMed ID: 20181636 [No Abstract] [Full Text] [Related]
34. Nonpropositional content in direct-to-consumer genetic testing advertisements. Borry P; Shabani M; Howard HC Am J Bioeth; 2013; 13(5):14-6. PubMed ID: 23557036 [No Abstract] [Full Text] [Related]
35. Pharmaceuticals and medical devices: business practices. Issue brief. Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840 [No Abstract] [Full Text] [Related]
36. Is banning direct-to-consumer advertising consistent with bioethical principles? O'Hara KM JAAPA; 2010 Aug; 23(8):54, 56-7. PubMed ID: 20821915 [No Abstract] [Full Text] [Related]
37. Yes, industry influence is excessive. Shah AA; Finucane TE Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608 [No Abstract] [Full Text] [Related]
38. "Will I be pretty, will I be rich?": the missing self in antidepressant commercials. Tekin S Am J Bioeth; 2013; 13(5):19-21. PubMed ID: 23557039 [No Abstract] [Full Text] [Related]
39. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts. Berger JT Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495 [No Abstract] [Full Text] [Related]
40. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry. Creyer EH; Hrsistodoulakis I Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]